Showing results (81-90 of 122) with videos related to
Sort By:
Pageof 13
Pharmacoepidemiology and Drug Safety|March 28, 2012
Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis-stimulating agent and transfusion use in chemotherapy-treated cancer patientsThomas J Arneson, Shuling Li, David T Gilbertson, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2022
Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapyJennifer Schenfeld, TingTing Gong, David Henry, et al.Frontiers in Immunology|October 3, 2022
Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysisShuling Li, Kuifei Chen, Meiwen Yang, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 11, 2025
Trends in Outcomes Among Patients Initiating Peritoneal Dialysis in the United States, 2009-2018Christopher Knapp, Shuling Li, Chuanyu Kou, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2020
Trends in use of primary prophylactic colony stimulating factors and neutropenia-related hospitalization in commercially insured patients receiving myelosuppressive chemotherapy in the United States: 2005-2017Jennifer R Schenfeld, Corina W Bennett, Shuling Li, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2013
Trends in hip fracture rates in US hemodialysis patients, 1993-2010Thomas J Arneson, Shuling Li, Jiannong Liu, et al.ACS Applied Materials & Interfaces|June 8, 2022
Basic Amino Acids Modulated Neutral-pH PEDOT:PSS for Stable Blue Perovskite Light-Emitting DiodesLihui Liu, Ruimin Dong, Honggang Ge, et al.Oncology Reports|August 31, 2016
miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related geneShuling Li, Xiaobing Wu, Yuandong Xu, et al.Oncology Reports|March 24, 2022
[Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancerYuandong Xu, Xuejuan Liu, Huizhong Zhang, et al.Journal of the American Society of Nephrology : JASN|January 21, 2026
Peritoneal Dialysis Initiation Patterns by Health Service Area during an Era of ExpansionChristopher D Knapp, Shuling Li, Chuanyu Kou, et al.Pageof 13